Reyataz and Burning sensation - a phase IV clinical study of FDA data

Summary:

Burning sensation is reported as a side effect among people who take Reyataz (atazanavir sulfate), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Norvir, and have Hepatic neoplasm malignant.

The phase IV clinical study analyzes which people have Burning sensation when taking Reyataz. It is created by eHealthMe based on reports of 11,228 people who have side effects when taking Reyataz from the FDA, and is updated regularly.

What is Reyataz?

Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. eHealthMe is studying from 11,386 Reyataz users. Check the latest studies of Reyataz.

What is Burning sensation?

Burning sensation is found to be associated with 2,016 drugs and 2,077 conditions by eHealthMe. Check the latest studies of Burning sensation.

On Aug, 08, 2026

11,228 people reported to have side effects when taking Reyataz.
Among them, 26 people (0.23%) have Burning sensation.

Among these 26 people:

How long have people been on Reyataz when they have Burning sensation? *

What is the gender of people who have Burning sensation when taking Reyataz? *

female: 20.83 %
male: 79.17 %

What is the age of people who have Burning sensation when taking Reyataz? *

What are other drugs people take besides Reyataz? *

What are other side effects people have besides Burning sensation? *

Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 7 people, 26.92%
Nausea And Vomiting: 7 people, 26.92%
Rashes (redness): 7 people, 26.92%
Indigestion: 6 people, 23.08%
Fatigue (feeling of tiredness): 5 people, 19.23%
Nausea (feeling of having an urge to vomit): 5 people, 19.23%
Eye Pruritus (eye itching): 4 people, 15.38%
Joint Stiffness: 4 people, 15.38%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 4 people, 15.38%
Erection Problems: 4 people, 15.38%

What are the existing conditions these people have? *

Hepatic Neoplasm Malignant (liver cancer): 4 people, 15.38%
Hepatitis C: 2 people, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.85%
Gastric Ulcer (stomach ulcer): 1 person, 3.85%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 3.85%
Chest X-Ray Abnormal: 1 person, 3.85%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Reyataz and have Burning sensation?

- Check whether Burning sensation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Reyataz:

Reyataz (11,386 reports)

Browse all side effects of Reyataz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Burning sensation:

Burning sensation (2,016 drugs)

Browse all the conditions that are associated with Burning sensation:

Burning sensation (2,077 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atazanavir sulfate (the active ingredients of Reyataz) and Reyataz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.